A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors (original) (raw)
Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby VJ, McNutt RW, Rothman RB, Rice KC, Porreca F (1995) SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther 273:359–366 CASPubMed Google Scholar
Bishop SJ (2007) Neurocognitive mechanisms of anxiety: an integrative account. Trends Cogn Sci 11:307–316 ArticlePubMed Google Scholar
Brown PL, Hurley C, Repucci N, Drugan RC (2001) Behavioral analysis of stress controllability effects in a new swim stress paradigm. Pharmacol Biochem Behav 68:263–272 ArticleCASPubMed Google Scholar
Chaki S, Nakazato A, Kennis L, Nakamura M, Mackie C, Sugiura M, Vinken P, Ashton D, Langlois X, Steckler T (2004) Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. Eur J Pharmacol 485:145–158 ArticleCASPubMed Google Scholar
Chiba T, Murase H, et al (1996) Antinociceptive activity of deltorphin analogs in the formalin test. Life Sci 59(20):1717–1722 ArticleCASPubMed Google Scholar
Chieng B, Christie MJ (2009) Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey. Neuropharmacology 57:430–437 ArticleCASPubMed Google Scholar
Chieng B, Christie MJ, Osborne PB (2006) Characterization of neurons in the rat central nucleus of the amygdale: cellular physiology, morphology, and opioid sensitivity. J Comp Neurol 497:910–927 ArticleCASPubMed Google Scholar
Devine DP, Wise RA (1994) Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci 14:1978–1984 CASPubMed Google Scholar
Emmerson PJ, Liu MR, Woods JH, Medzihradsky F (1994) Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther 271:1630–1637 CASPubMed Google Scholar
Fang L, Knapp RJ, Horvath R, Matsunaga TO, Haaseth RC, Hruby VJ, Porreca F, Yamamura HI (1994) Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity. J Pharmacol Exp Ther 268:836–846 CASPubMed Google Scholar
Fanselow MS, Helmstetter FJ (1988) Conditional analgesia, defensive freezing, and benzodiazepines. Behav Neurosci 102:233–243 ArticleCASPubMed Google Scholar
Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gaveriaux-Ruff C, Dierich A, LeMeur M, Valverde O, Maldonado R, Kieffer BL (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25:195–200 ArticleCASPubMed Google Scholar
Gallantine EL, Meert TF (2005) A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80. Basic Clin Pharmacol Toxicol 97(1):39–51 ArticleCASPubMed Google Scholar
Garakani A, Mathew SJ, Charney DS (2006) Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med 73:941–949 PubMed Google Scholar
Hirata H, Sonoda S, Agui S, Yoshida M, Ohinata K, Yoshikawa M (2007) Rubiscolin-6, a delta opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating sigma1 and dopamine D1 receptors. Peptides 28:1998–2003 ArticleCASPubMed Google Scholar
Israel Y, Kandov Y, et al (2005) NPY-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. Peptides 26(7):1167–1175 ArticleCASPubMed Google Scholar
Jutkiewicz EM (2006) The antidepressant -like effects of delta-opioid receptor agonists. Mol Interv 6:162–169 ArticleCASPubMed Google Scholar
Kameyama T, Nagasaka M (1982) The effects of analgesics on quickly-learned conditioned suppression in mice. Neuropharmacology 21:1283–1289 ArticleCASPubMed Google Scholar
Kang W, Wilson SP, Wilson MA (1999) Changes in nociceptive and anxiolytic responses following herpes virus-mediated preproenkephalin overexpression in rat amygdala are naloxone-reversible and transient. Ann N Y Acad Sci 877:751–755 ArticleCASPubMed Google Scholar
Kang W, Wilson SP, et al (2000) Overexpression of proenkephalin in the amygdala potentiates the anxiolytic effects of benzodiazepines. Neuropsychopharmacology 22(1):77–88 ArticleCASPubMed Google Scholar
Konig M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A (1996) Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383:535–538 ArticleCASPubMed Google Scholar
Korte SM, DeBoer SF (2003) A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol 463:163–175 ArticlePubMed Google Scholar
Mansour A, Fox CA, Akil H, Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22–29 ArticleCASPubMed Google Scholar
Mosberg HI, Hurst R, Hruby VJ, Gee K, Yamamura HI, Galligan JJ, Burks TF (1983) Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc Natl Acad Sci U S A 80:5871–5874 ArticleCASPubMed Google Scholar
Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, Suzuki T (2006a) Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31:739–750 ArticleCASPubMed Google Scholar
Narita M, Kuzumaki N, Kaneko C, Tamai E, Khotib J, Miyatake M, Shindo K, Nagumo Y, Tanaka S, Suzuki T (2006b) Age-related emotionality is associated with cortical delta-opioid receptor dysfunction-dependent astrogliosis. Neuroscience 137:1359–1367 ArticleCASPubMed Google Scholar
Nieto MM, Guen SL, Kieffer BL, Roques BP, Noble F (2005) Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience 135:305–313 ArticleCASPubMed Google Scholar
Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Elsevier, Elsevier Google Scholar
Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167 ArticleCASPubMed Google Scholar
Perrine SA, Hoshaw BA, Unterwald EM (2006) Delta opioid receptor ligands modulate anxiety-like behaviors in the rat. Br J Pharmacol 147:864–872 ArticleCASPubMed Google Scholar
Pollier F, Sarre S, Aguerre S, Ebinger G, Mormede P, Michotte Y, Chaouloff F (2000) Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality. Neuropsychopharmacology 22:64–76 ArticleCASPubMed Google Scholar
Portoghese PS, Sultana M, Nagase H, Takemori AE (1988a) Application of the message-address concept in the design of highly potent and selective non-peptide delta opioid receptor antagonists. J Med Chem 31:281–282 ArticleCASPubMed Google Scholar
Portoghese PS, Sultana M, Takemori AE (1988b) Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur J Pharmacol 146:185–186 ArticleCASPubMed Google Scholar
Primeaux SD, Wilson SP, McDonald AJ, Mascagni F, Wilson MA (2006) The role of delta opioid receptors in the anxiolytic actions of benzodiazepines. Pharmacol Biochem Behav 85:545–554 ArticleCASPubMed Google Scholar
Ragnauth A, Schuller A, Morgan M, Chan J, Ogawa S, Pintar J, Bodnar RJ, Pfaff DW (2001) Female preproenkephalin-knockout mice display altered emotional responses. Proc Natl Acad Sci U S A 98:1958–1963 ArticleCASPubMed Google Scholar
Ramos A, Berton O, Mormede P, Chaouloff F (1997) A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res 85:57–69 ArticleCASPubMed Google Scholar
Ramos A, Mellerin Y, Mormede P, Chaouloff F (1998) A genetic and multifactorial analysis of anxiety-related behaviours in Lewis and SHR intercrosses. Behav Brain Res 96:195–205 ArticleCASPubMed Google Scholar
Ramos A, Kangerski AL, Basso PF, Da Silva Santos JE, Assreuy J, Vendruscolo LF, Takahashi RN (2002) Evaluation of Lewis and SHR rat strains as a genetic model for the study of anxiety and pain. Behav Brain Res 129:113–123 ArticlePubMed Google Scholar
Rodgers RJ, Dalvi A (1997) Anxiety, defense and the elevated plus-maze. Neurosci Biobehav Rev 21:801–810 ArticleCASPubMed Google Scholar
Rodgers RJ, Johnson NJ (1995) Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52:297–303 ArticleCASPubMed Google Scholar
Rogers H, Hayes AG, Birch PJ, Traynor JR, Lawrence AJ (1990) The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors. J Pharm Pharmacol 42:358–359 CASPubMed Google Scholar
Rosen JB (2004) The neurobiology of conditioned and unconditioned fear: a neurobehavioral system analysis of the amygdala. Behav Cogn Neurosci Rev 3:23–41 ArticlePubMed Google Scholar
Saitoh A, Kimura Y, Suzuki T, Kawai K, Nagase H, Kamei J (2004) Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J Pharmacol Sci 95:374–380 ArticleCASPubMed Google Scholar
Saitoh A, Yoshikawa Y, Onodera K, Kamei J (2005) Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats. Psychopharmacology (Berl) 182:327–334 ArticleCAS Google Scholar
Sharif NA, Hughes J (1989) Discrete mapping of brain Mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors. Peptides 10:499–522 ArticleCASPubMed Google Scholar
Wall PM, Messier C (2001) Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neurosci Biobehav Rev 25:275–286 ArticleCASPubMed Google Scholar